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Procyanidins are polyphenolic compounds that have come to be known as 
biologically active in the context of promoting human health. Epidemiological evidence 
suggests that populations that consume diets rich in procyanidins are less susceptible to 
inflammatory diseases. Allergic asthma is an inflammatory lung disease with an 
estimated 100 million affected individuals worldwide, with New Zealand having the 
world’s second highest rate. Inflammation at the airway epithelium and infiltration of 
immune cells, specifically eosinophils, into the lung tissue are two central 
characteristics of allergic asthma. Thymic stromal lymphopoietin (TSLP) and eotaxin 
isoforms, eotaxin-1 (CCL11) and eotaxin-3 (CCL26), are three biomarkers of airway 
inflammation produced by the epithelium. Cell culture models were successfully 
optimized for CCL11 and CCL26 production in A549 cells. Investigation of 
procyanidins effect on epithelial TSLP production was not possible because TSLP 
production in A549 cells was undetectable. Data suggests that dimeric A-type linked 
procyanidin A2, but not B-type linked procyanidin B1 or B2, is capable of inhibiting 
IL-4-induced CCL11 production when incubated on A549 cells prior to an 
inflammatory insult. Co-incubation of A549 cells with procyanidin A2 and procyanidin 
B2 demonstrated no evidence of a synergistic relationship for inhibiting cytokine-
iii 
 
induced CCL11 production. Similarly, A549 cells exposed to procyanidin A2, and to a 
lesser extent procyanidin B2, had reduced production of cytokine-induced CCL26 
production. An inhibition time course demonstrated procyanidin A2 had greatest 
inhibition efficacy on cytokine-induced CCL26 production when incubated for 2 h prior 
to an inflammatory insult. Comparison of procyanidin A2 inhibition to the known 
CCL26 inhibitor, IFN?, demonstrated that procyanidin A2 and IFN? did not share the 
same temporal inhibition patterns. Furthermore, experiments investigating concomitant 
incubation of procyanidin A2 and IFN? demonstrated that procyanidin A2 could 
interfere with IFN?–mediated CCL26 inhibition. Two possible mechanisms responsible 
for the procyanidin A–mediated inhibition of cytokine-induced CCL11 and CCL26 
were investigated: the modulation of cytokine receptor expression, and modulation of 
plasma membrane fluidity. However, there was no evidence to support either of these 
modes of action. The data presented in this thesis collectively demonstrate the ability of 
procyanidin A2 to inhibit cytokine-induced eotaxin production from the lung epithelium 
in vitro and support further investigation of procyanidin A2 as a preventative approach 
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